RA Drug May Help Treat Recalcitrant Eczema
Treatment with the janus kinase (JAK) inhibitor XELJANZ® (tofacitinib citrate) led to dramatic improvement in six patients with moderate to severe eczema who had previously failed conventional therapies.
Treatment with the janus kinase (JAK) inhibitor XELJANZ® (tofacitinib citrate) led to dramatic improvement in six patients with moderate to severe eczema who had previously failed conventional therapies.
Plastic surgeon Johnny Franco, MD, discusses how his firsthand experience with GLP-1s shaped his patient-centered wellness program and what plastic surgeons should know before adding similar treatments to their aesthetic practices.